Remedy Surges in Sales and Profit with Alan Wake 2; CEO Tero Virtala on Future Projects and Self-Publishing Possibilities.

Royalties and development fees boost turnover as Remedy’s operating loss is less than anticipated

Remedy, a gaming company, reported that its newest game continues to be popular and is selling at high prices. The company is already looking ahead to future projects and the possibility of self-publishing games. Despite an operating loss of EUR 2.1 million and a turnover of EUR 10.8 million in the beginning of the year, analysts had forecasted a larger loss at EUR 7.5 million, with turnover at EUR 7.1 million.

The success of Alan Wake 2, which was released at the end of last year and has sold 1.3 million copies as of February, has contributed to Remedy’s recent growth. Looking ahead, Remedy’s CEO Tero Virtala stated that the company’s focus is on developing new projects, including additional content for Alan Wake 2. The outlook for the year remains unchanged with expectations of increased turnover and improved operating profit.

Remedy’s future success will depend on whether they decide to self-publish or find a new partner for upcoming games like Codename Condor and Control 2 that are currently in development. With these projects set to impact their financial results in the coming year, Remedy remains optimistic about its future prospects and committed to delivering high-quality gaming experiences to its fans.

Leave a Reply